Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

17

Number of overlapping holdings

37.8%

% of IDNA's 49 holdings also in BBP

27.9%

% of BBP's 65 holdings also in IDNA

Overlap by Weight
Sector Drift (IDNA minus BBP)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in IDNA
Weight
in BBP
Overlap
LIGAND PHARMACEUTICALS-CL B 2.4% 1.9% 1.9%
GILEAD SCIENCES INC 5.7% 1.8% 1.8%
SAREPTA THERAPEUTICS INC 4.3% 1.7% 1.7%
BIOCRYST PHARMACEUTICALS INC 1.6% 1.8% 1.6%
INCYTE CORP 5.0% 1.6% 1.6%

Position Highlights (Non-Overlapping Exposures)
IDNA Overweight Relative to BBP
REVOLUTION MEDICINES, INC. 5.7%
BEIGENE, LTD. 5.4%
EXELIXIS INC 5.1%
ROCHE HOLDING LTD 4.3%
TAKEDA PHARMACEUTICAL CO LTD 4.0%
SANOFI-AVENTIS 4.0%
GILEAD SCIENCES INC 3.9%
ARCELLX, INC. 3.9%
INCYTE CORP 3.4%
BIONTECH SE SPONSORED ADR 3.4%
IDNA Underweight Relative to BBP
MIRUM PHARMACEUTICALS, INC. -2.4%
ALNYLAM PHARMACEUTICALS INC -2.1%
TRAVERE THERAPEUTICS, INC. -2.0%
LEXICON PHARMACEUTICALS, INC. -1.9%
LEGEND BIOTECH CORPORATION SPONSORED -1.9%
ACADIA PHARMACEUTICALS INC -1.9%
IONIS PHARMACEUTICALS, INC. -1.8%
DAY ONE BIOPHARMACEUTICALS, INC. -1.8%
TG THERAPEUTICS INC -1.8%
ADMA BIOLOGICS, INC. -1.8%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY